Welcome to Cato Research - a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.
Cato Research is now using Twitter! Follow us to keep up to date on the latest Cato news and events.
December 9, 2009 - Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy ![]()
November 3, 2009 - Immunovaccine Inc. Announces Master Services Agreement with Cato Research Canada ![]()
October 5, 2009 - Cato Research becomes GlobalSubmit's Signature Partner ![]()
July 21, 2009 - Abstract accepted for ECCO 15 - 34th ESMO Multidisciplinary Congress ![]()
February 27, 2009 - Alseres Pharmaceuticals Inc. Announces Securities Purchase Agreement with Cato Bioventures ![]()